BeOne Medicines (ONC) Prepaid Assets (2015 - 2026)
BeOne Medicines (ONC) reported Prepaid Assets of $190.0 million for Q1 2026, up 12.97% year-over-year from $168.2 million in Q1 2025, and down 10.7% quarter-over-quarter from $212.8 million in Q4 2025.
BeOne Medicines (ONC) Prepaid Assets (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has 12 years of Prepaid Assets data on file, last reported at $190.0 million in Q1 2026.
- Prepaid Assets for Q1 2026 came in at $190.0 million, up 12.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $190.0 million (up 12.97% YoY), and the FY2025 annual result was $212.8 million, up 10.28% from the prior year.
- Prepaid Assets slipped to $190.0 million in Q1 2026 per ONC's latest filing, from $212.8 million in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.4 billion in Q4 2022 and troughed at $168.2 million in Q1 2025.
- A 5-year average of $296.4 million and a median of $232.6 million in 2025 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 401.27% in 2022, then tumbled 80.99% in 2023.
- A 5-year view of Prepaid Assets shows it stood at $1.4 billion in 2022, then plunged by 80.99% to $257.5 million in 2023, then decreased by 25.07% to $192.9 million in 2024, then increased by 10.28% to $212.8 million in 2025, then declined by 10.7% to $190.0 million in 2026.
- Business Quant data shows ONC's Prepaid Assets at $190.0 million in Q1 2026, $212.8 million in Q4 2025, and $232.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190.00 Mn |
| Dec 31, 2025 | 212.75 Mn |
| Sep 30, 2025 | 232.64 Mn |
| Jun 30, 2025 | 280.52 Mn |
| Mar 31, 2025 | 168.18 Mn |
| Dec 31, 2024 | 192.92 Mn |
| Sep 30, 2024 | 209.08 Mn |
| Jun 30, 2024 | 273.66 Mn |
| Mar 31, 2024 | 231.74 Mn |
| Dec 31, 2023 | 257.47 Mn |
| Sep 30, 2023 | 241.66 Mn |
| Jun 30, 2023 | 255.05 Mn |
| Mar 31, 2023 | 264.84 Mn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 199.77 Mn |
| Jun 30, 2022 | 207.38 Mn |
| Mar 31, 2022 | 266.44 Mn |
| Dec 31, 2021 | 270.17 Mn |
| Sep 30, 2021 | 235.02 Mn |
| Jun 30, 2021 | 225.46 Mn |